We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
+8.93%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$7.1B
AUM Growth
+$407M
Cap. Flow
-$92.2M
Cap. Flow %
-1.3%
Top 10 Hldgs %
23.68%
Holding
2,973
New
384
Increased
1,273
Reduced
905
Closed
264

Sector Composition

Rank Sector Weight
1 Technology 22.98%
2 Consumer Discretionary 12.04%
3 Financials 12.03%
4 Healthcare 11.82%
5 Industrials 8.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CATO icon
2401
Cato Corp
CATO
$66.7M
$101K ﹤0.01%
+6,005
New +$88.9K
AMNB
2402
DELISTED
American National Bankshares Inc
AMNB
$101K ﹤0.01%
3,249
QVCGA
2403
DELISTED
QVC Group Inc Series A
QVCGA
$101K ﹤0.01%
154
INVE icon
2404
Identive
INVE
$64.1M
$100K ﹤0.01%
+5,908
New +$89.2K
MCBS icon
2405
MetroCity Bankshares
MCBS
$1.05B
$100K ﹤0.01%
+5,721
New +$94.9K
XONE
2406
DELISTED
The ExOne Company
XONE
$98.6K ﹤0.01%
4,555
+349
+8% +$7.94K
DCT
2407
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
$98.3K ﹤0.01%
2,259
-2,362
-51% -$96.1K
YELL
2408
DELISTED
Yellow Corporation Common Stock
YELL
$98.1K ﹤0.01%
+15,070
New +$112K
BCOV
2409
DELISTED
Brightcove, Inc.
BCOV
$97.7K ﹤0.01%
6,809
-4,869
-42% -$78.2K
SPRO icon
2410
Spero Therapeutics
SPRO
$71.8M
$97.5K ﹤0.01%
6,987
+1,802
+35% +$25.2K
GRTS
2411
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$97.2K ﹤0.01%
10,649
+2,972
+39% +$27.5K
MBI icon
2412
MBIA
MBI
$262M
$96.7K ﹤0.01%
8,789
-6,451
-42% -$64.3K
RES icon
2413
RPC Inc
RES
$1.39B
$96.6K ﹤0.01%
+19,525
New +$105K
ALT icon
2414
Altimmune
ALT
$560M
$96.5K ﹤0.01%
+9,799
New +$134K
FLL icon
2415
Full House Resorts
FLL
$84.3M
$96.5K ﹤0.01%
+9,705
New +$94K
EMKR
2416
DELISTED
Emcore Corp
EMKR
$95.9K ﹤0.01%
+1,040
New +$84K
LAZ icon
2417
Lazard
LAZ
$4.43B
$95.3K ﹤0.01%
2,106
+64
+3% +$2.94K
RITM icon
2418
Rithm Capital
RITM
$5.79B
$94.8K ﹤0.01%
8,950
+560
+7% +$5.95K
CVM icon
2419
CEL-SCI Corp
CVM
$26M
$93.7K ﹤0.01%
360
+44
+14% +$27.2K
NPKI
2420
NPK International
NPKI
$1.18B
$93.3K ﹤0.01%
+26,967
New +$91.5K
AL
2421
DELISTED
Air Lease Corp
AL
$92.4K ﹤0.01%
2,213
+57
+3% +$2.65K
PRLD icon
2422
Prelude Therapeutics
PRLD
$428M
$91.4K ﹤0.01%
3,194
+315
+11% +$11.2K
CPLG
2423
DELISTED
CorePoint Lodging Inc. Common Stock
CPLG
$91.2K ﹤0.01%
8,521
-6,766
-44% -$67.9K
NGNE icon
2424
Neurogene
NGNE
$713M
$91.1K ﹤0.01%
494
WLK icon
2425
Westlake Corp
WLK
$10.2B
$90.7K ﹤0.01%
1,007
+321
+47% +$31.2K

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q2 2021 Portfolio in Review

As of Q2 2021, Metropolitan Life Insurance Company (MetLife) held 2,973 positions worth $7.1B, up 6.1% from $6.69B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q2 2021 filing shows 384 new, 1,273 increased, 905 reduced and 264 closed positions. Its largest new stake was Palantir: 112,538 shares worth $2.97M. The largest sale was Alphabet (Google) Class C, an estimated $96.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q2 2021 buy was Palantir: 112,538 shares worth $2.97M.
  • Metropolitan Life Insurance Company (MetLife) added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $33.8M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q2 2021 reduction was UnitedHealth, cutting an estimated $16M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Alphabet (Google) Class C in Q2 2021, selling an estimated $96.8M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 24% of its $7.1B portfolio in Q2 2021.
  • Metropolitan Life Insurance Company (MetLife) opened 384 new positions and closed 264 in Q2 2021.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 6.1% quarter-over-quarter to $7.1B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2021, filed 16 Aug 2021.